These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8586293)

  • 1. [Oral hormonal contraception: more or less estrogens?].
    Rubio Lotvin B
    Ginecol Obstet Mex; 1995 Dec; 63():497-8. PubMed ID: 8586293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The desogestrel-ethinyl estradiol combination and overweight: current data].
    Rubio Lotvin B
    Ginecol Obstet Mex; 1995 Nov; 63():483-6. PubMed ID: 8537039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical experience of a combined oral contraceptive with very low dose ethinyl estradiol.
    Akerlund M
    Acta Obstet Gynecol Scand Suppl; 1997; 164():63-5. PubMed ID: 9225641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Route of administration of contraceptives containing desogestrel/etonorgestrel and insulin sensitivity: a prospective randomized study.
    Cagnacci A; Ferrari S; Tirelli A; Zanin R; Volpe A
    Contraception; 2009 Jul; 80(1):34-9. PubMed ID: 19501213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A combiphasic oral contraceptive containing ethinylestradiol and desogestrel].
    Poulsen HK
    Ugeskr Laeger; 1995 Aug; 157(32):4473-5. PubMed ID: 7483033
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of body composition during low-dose estrogen oral contraceptives treatment.
    Franchini M; Caruso C; Nigrelli S; Poggiali C
    Acta Eur Fertil; 1995; 26(2):69-73. PubMed ID: 9098463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects on acne of two oral contraceptives containing desogestrel and cyproterone acetate.
    Charoenvisal C; Thaipisuttikul Y; Pinjaroen S; Krisanapan O; Benjawang W; Koster A; Doesburg W
    Int J Fertil Menopausal Stud; 1996; 41(4):423-9. PubMed ID: 8894800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A large observational clinical evaluation of a desogestrel-containing combiphasic oral contraceptive in Germany.
    Vree ML; Schmidt J
    Eur J Contracept Reprod Health Care; 2001 Jun; 6(2):108-14. PubMed ID: 11518448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of contraceptive with 20 ug ethinylestradiol and 150 ug desogestrel on some acute phase proteins].
    Uchikova E; Batashki I; Milchev N; Mateva N; Markova D; Gŭrova A
    Akush Ginekol (Sofiia); 2006; 45(2):39-43. PubMed ID: 16637303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Desogestrel+ethinylestradiol versus levonorgestrel+ethinylestradiol. Which one has better affect on acne, hirsutism, and weight change.
    Sanam M; Ziba O
    Saudi Med J; 2011 Jan; 32(1):23-6. PubMed ID: 21212911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical study of low-dose oral contraceptives (with low-doses of ethinyl estradiol), widely used in practice].
    Nalbanski B; Tsekova K; Ivanov S
    Akush Ginekol (Sofiia); 2001; 41 Suppl 4():20-3. PubMed ID: 11519317
    [No Abstract]   [Full Text] [Related]  

  • 12. A randomized cross-over study on the effects of levonorgestrel- and desogestrel-containing oral contraceptives on the anticoagulant pathways.
    Tans G; Curvers J; Middeldorp S; Thomassen MC; Meijers JC; Prins MH; Bouma BN; Büller HR; Rosing J
    Thromb Haemost; 2000 Jul; 84(1):15-21. PubMed ID: 10928463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of hormonal contraception on bone mineral density after 24 months of use.
    Berenson AB; Breitkopf CR; Grady JJ; Rickert VI; Thomas A
    Obstet Gynecol; 2004 May; 103(5 Pt 1):899-906. PubMed ID: 15121563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Endometrial interference of synthetic estrogens in fertility regulation.Is it necessary to interfere with the antiovulatory mechanism at the central nervous system level in order to obtain contraception?].
    Sojo Aranda QI; Rojas T; Cortés-Gallegos V
    Ginecol Obstet Mex; 1997 Oct; 65():449-51. PubMed ID: 9432479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone mineral density in young, hypothalamic oligoamenorrheic women treated with oral contraceptives.
    Castelo-Branco C; Vicente JJ; Pons F; Martínez de Osaba MJ; Casals E; Vanrell JA
    J Reprod Med; 2001 Oct; 46(10):875-9. PubMed ID: 11725730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rationale for new oral contraceptive dosing.
    Williams JK
    Int J Fertil Womens Med; 2004; 49(1):30-5. PubMed ID: 15038507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effect on acne with a combiphasic desogestrel-containing oral contraceptive and a preparation containing cyproterone acetate.
    Vartiainen M; de Gezelle H; Broekmeulen CJ
    Eur J Contracept Reprod Health Care; 2001 Mar; 6(1):46-53. PubMed ID: 11334476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Oral contraceptives: 30 vs 20 micrograms of ethinyl estradiol (EE)].
    Urdinola J
    Adv Contracept; 1994 Jul; 10 Suppl 1():41-9. PubMed ID: 7839871
    [No Abstract]   [Full Text] [Related]  

  • 19. A prospective study of a monophasic oral contraceptive containing 30 mcg ethinyl oestradiol and 150 mcg desogestrel (Marvelon).
    Ismail MT
    Malays J Reprod Health; 1994 Jun; 12(1):43-8. PubMed ID: 12320338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contraceptives.
    Quehenberger P; Loner U; Kapiotis S; Handler S; Schneider B; Huber J; Speiser W
    Thromb Haemost; 1996 Nov; 76(5):729-34. PubMed ID: 8950781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.